The strongest predictor of whether a man is developing dementia with Lewy bodies - the second most common form of dementia in the elderly - is whether he acts out his dreams while sleeping, Mayo Clinic researchers have discovered.
Patients are five times more likely to have dementia with Lewy bodies if they experience a condition known as rapid eye movement (REM) sleep behaviour disorder than if they have one of the risk factors now used to make a diagnosis, such as fluctuating cognition or hallucinations, the study found.
It can appear three decades or more before a diagnosis of dementia with Lewy bodies is made in males, the researchers said. The link between dementia with Lewy bodies and the sleep disorder is not as strong in women, they added.
"While it is, of course, true that not everyone who has this sleep disorder develops dementia with Lewy bodies, as many as 75 to 80 per cent of men with dementia with Lewy bodies in our Mayo database did experience REM sleep behaviour disorder. So it is a very powerful marker for the disease," said lead investigator Melissa Murray, a neuroscientist at Mayo Clinic in Florida.
More From This Section
"Screening for the sleep disorder in a patient with dementia could help clinicians diagnose either dementia with Lewy bodies or Alzheimer's disease," she said.
"It can sometimes be very difficult to tell the difference between these two dementias, especially in the early stages, but we have found that only 2 to 3 per cent of patients with Alzheimer's disease have a history of this sleep disorder," she added.
Researchers at Mayo Clinic in Minnesota and Florida, led by Murray, examined magnetic resonance imaging, or MRI, scans of the brains of 75 patients diagnosed with probable dementia with Lewy bodies. A low-to-high likelihood of dementia was made upon an autopsy examination of the brain.
The researchers also showed that low-probability dementia with Lewy bodies patients who did not have the sleep disorder had findings characteristic of Alzheimer's disease.
The findings were presented at the annual meeting of the American Academy of Neurology in San Diego.